The Prevalence and Clinical Characteristics of Borderline Personality Disorder in South Korea Using National Health Insurance Service Customized Database

다국어 초록 (Multilingual Abstract)

Purpose: The purpose of the present study was to identify the prevalence and clinical characteristics of borderline personality disorder (BPD) in South Korea using the Korean National Health Insurance database (DB).
Materials and Methods: We used the National Health Insurance Service (NHIS)’s research DB (NHIS-2021-1-790) from January 1, 2010 to December 31, 2019, to make customized DB including sociodemographic information and absence or presence of BPD and other psychiatric disorders. The prevalence and the age of onset of BPD was estimated. To compare medical service utiliza tion between the BPD group and the control group, a 1:1:1 propensity score matching was employed, and the regression analysis was conducted.
Results: The prevalence of BPD per 10000 people was 0.96 in 2010 and 1.06 in 2019. The prevalence ratio of males to females was 1:1.38 in 2010 and 1:1.65 in 2019, showing that BPD was more prevalent in females. The patients’ overall average age of onset was 33.19±14.6 years, with the highest prevalence shown in 8503 people in their 20s. By administrative district, the highest prevalence of BPD per 10000 people was shown in Seoul with 8.71 and the lowest in Jeollanam-do with 2.35. The BPD patients showed a pat tern of extensive use of general and mental healthcare services.
Conclusion: This study identified the prevalence of BPD on a national DB set in South Korea. Although the prevalence of BPD in South Korea was relatively low compared to other countries, there was a steady increase in the number of BPD patients over a de cade, which may be possibly due to an increased awareness of mental health and campaigns among healthcare providers and users in the country.

참고문헌 (Reference)

1 Bender DS, "Treatment utilization by patients with personality disorders" 158 : 295-302, 2001

2 Torgersen S, "The prevalence of personality disorders in a community sample" 58 : 590-596, 2001

3 Crawford MJ, "The prevalence of personality disorder among ethnic minorities : findings from a national household survey" 6 : 175-182, 2012

4 McGlashan TH, "The collaborative longitudinal personality disorders study : baseline axis I/II and II/II diagnostic co-occurrence" 102 : 256-264, 2000

5 Skodol AE, "The borderline diagnosis I : psychopathology, comorbidity, and personality structure" 51 : 936-950, 2002

6 Zanarini MC, "The 10-year course of physically self-destructive acts reported by borderline patients and axis II comparison subjects" 117 : 177-184, 2008

7 Soloff PH, "Symptom-oriented psychopharmacology for personality disorders" 4 : 3-11, 1998

8 Trull TJ, "Revised NESARC personality disorder diagnoses : gender, prevalence, and comorbidity with substance dependence disorders" 24 : 412-426, 2010

9 Aragonès E, "Registered prevalence of borderline personality disorder in primary care databases" 27 : 171-174, 2013

10 Grant BF, "Prevalence, correlates, disability, and comorbidity of DSMIV borderline personality disorder : results from the wave 2 national epidemiologic survey on alcohol and related conditions" 69 : 533-545, 2008

11 Coid J, "Prevalence and correlates of personality disorder in Great Britain" 188 : 423-431, 2006

12 Zanarini MC, "Prediction of the 10-year course of borderline personality disorder" 163 : 827-832, 2006

13 Newton-Howes G, "Personality disorder prevalence and correlates in a whole of nation dataset" 56 : 679-685, 2021

14 Skodol AE, "Is there a characteristic pattern to the treatment history of clinic outpatients with borderline personality?" 171 : 405-410, 1983

15 Swartz M, "Estimating the prevalence of borderline personality disorder in the community" 4 : 257-272, 1990

16 Korzekwa MI, "Estimating the prevalence of borderline personality disorder in psychiatric outpatients using a two-phase procedure" 49 : 380-386, 2008

17 Lenzenweger MF, "Detecting personality disorders in a nonclinical population. Application of a 2-stage procedure for case identification" 54 : 345-351, 1994

18 Lenzenweger MF, "DSM-IV personality disorders in the national comorbidity survey replication" 62 : 553-564, 2007

19 Samuels JF, "DSM-III personality disorders in the community" 151 : 1055-1062, 1994

20 Sansone RA, "Chronic suicidality and borderline personality" 18 : 215-225, 2004

21 Tomko RL, "Characteristics of borderline personality disorder in a community sample : comorbidity, treatment utilization, and general functioning" 28 : 734-750, 2014

22 Jencks SF, "Change in the quality of care delivered to medicare beneficiaries, 1998-1999 to 2000-2001" 289 : 305-312, 2003

23 Gross R, "Borderline personality disorder in primary care" 162 : 53-60, 2002

24 Oldham JM, "Borderline personality disorder and suicidality" 163 : 20-26, 2006

25 Clarke M, "Borderline personality disorder : a challenge for mental health services" 29 : 409-414, 1995

26 Lieb K, "Borderline personality disorder" 364 : 453-461, 2004

27 de Bernier GL, "A systematic review of the global prevalence of personality disorders in adult Asian populations" 8 : 264-275, 2014

28 McGilloway A, "A systematic review of personality disorder, race and ethnicity : prevalence, aetiology and treatment" 10 : 33-, 2010

29 Paris J, "A 27-year follow-up of patients with borderline personality disorder" 42 : 482-487, 2001